Epidemiological Study on Case Definition of Methicillin-Resistant Staphylococcus aureus Enteritis
DOI: https://doi.org/10.2147/idr.s459708
2024-06-04
Infection and Drug Resistance
Abstract:Yusuke Yagi, 1, 2 Akito Doke, 1, 3 Saya Iwame, 1, 3 Yu Arakawa, 1, 4 Yuka Yamagishi 1, 4 1 Department of Infection Prevention and Control, Kochi Medical School Hospital, Nankoku, Kochi, Japan; 2 Department of Pharmacy, Kochi Medical School Hospital, Nankoku, Kochi, Japan; 3 Department of Clinical Laboratory, Kochi Medical School Hospital, Nankoku, Kochi, Japan; 4 Department of Clinical Infectious Diseases, Kochi Medical School, Kochi University, Nankoku, Kochi, Japan Correspondence: Yuka Yamagishi, Department of Clinical Infectious Diseases, Kochi Medical School, Kochi University, Nankoku, Kochi, 783-8505, Japan, Tel +81 88 866 5811, Fax +81 88 880 2611, Email Background: Methicillin-resistant Staphylococcus aureus (MRSA) enteritis is a condition in which MRSA grows abnormally in the intestine after administration of antimicrobial agents, resulting in enteritis. Patients with MRSA detected in stool culture tests are often diagnosed with MSRA enteritis. However, uncertainty remains in the diagnostic criteria; therefore, we conducted epidemiological studies to define these cases. Patients and Methods: Patients who tested positive for MRSA by stool culture using selective media 48 h after admission to Kochi Medical School Hospital between April 1, 2012, and December 31, 2022, and did not meet the exclusion criteria were included. We defined MRSA enteritis (Group A) as cases that were responsive to treatment with vancomycin hydrochloride powder, had a Bristol Stool Scale of ≥ 5, and a stool frequency of at least three times per day; all others were MRSA carriers (Group B). Multivariate analysis was performed to risk factors associated with MRSA enteritis. Results: Groups A and B included 18 (25.4%) and 53 (74.6%) patients, respectively. Multivariate logistic regression analysis showed that a white blood cell count of > 10000/μL (odds ratio [OR], 5.50; 95% confidence interval [CI], 1.12– 26.9), MRSA count of ≥ 2+ in stool cultures (OR, 8.91; 95% CI, 1.79– 44.3), and meropenem administration within 1 month of stool specimen submission (OR, 7.47; 95% CI, 1.66– 33.6) were risk factors of MRSA enteritis. Conclusion: The case definitions reviewed for MRSA enteritis may be useful as diagnostic criteria. Keywords: MRSA enteritis, diagnostic criteria, white blood cell, MRSA counts in stool cultures, meropenem Graphical Methicillin-resistant Staphylococcus aureus (MRSA) is the most frequently isolated nosocomial antibiotic-resistant bacterium and a problematic organism in healthcare-associated infections. 1 MRSA enteritis is a condition in which MRSA grows abnormally in the intestine after administration of antimicrobial agents, resulting in enteritis. Patients with MRSA detected in stool culture tests are often diagnosed with MRSA enteritis. 2,3 In Japan, MRSA enteritis is characterized by profuse watery diarrhea and has been reported to occur in older individuals, postoperatively in patients who underwent gastrectomy, and immunocompromised patients, and as a bacterial shift phenomenon after the administration of third-generation cephalosporin antibacterial agents. 4 Furthermore, MRSA enteritis was most frequently observed in the late 1980s and the early 1990s, 5,6 and since then, severe cases and deaths due to MRSA enteritis have become rare, and the number of cases has markedly decreased. 7 In addition, while the efficacy of screening for MRSA using chromogenic media has been reported, its diagnostic utility remains uncertain. 8 This is due to the lack of a firm definition of MRSA enteritis, which is caused by a lack of definition of diarrheal symptoms and frequency, inadequate studies on the number of MRSA detected, lack of routine examination of virulence factors and lack of pathological studies. 9 In contrast, Clostridioides difficile infection (CDI) is often observed in healthcare facilities, 10 and appropriate diagnostic criteria have been established. 11 Uncertainty remains in the diagnostic criteria of MRSA enteritis; therefore, we considered that a case definition for the diagnostic criteria of MRSA enteritis was required. We retrospectively examined the clinical characteristics and associated factors of cases where MRSA was detected in stool culture tests. This retrospective cohort study was conducted at Kochi Medical School Hospital between April 1, 2012, and December 31, 2022. Patients who tested positive for MRSA after submitting a diarrhea stool specimen were included. If the same patient submitted multiple stool specimens between admission and -Abstract Truncated-
pharmacology & pharmacy,infectious diseases